These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29078015)

  • 1. Cost of visceral leishmaniasis care in Brazil.
    de Carvalho IPSF; Peixoto HM; Romero GAS; de Oliveira MRF
    Trop Med Int Health; 2017 Dec; 22(12):1579-1589. PubMed ID: 29078015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.
    Meheus F; Boelaert M; Baltussen R; Sundar S
    Trop Med Int Health; 2006 Nov; 11(11):1715-24. PubMed ID: 17054752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
    Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
    PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of diagnostic tests for human visceral leishmaniasis in Brazil.
    Machado de Assis TS; Azeredo-da-Silva AL; Werneck GL; Rabello A
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):464-71. PubMed ID: 27618920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario.
    Freire ML; de Souza A; Cota G; Rabello A; Machado de Assis T
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008741. PubMed ID: 33031382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of visceral leishmaniasis for households in Nepal.
    Rijal S; Koirala S; Van der Stuyft P; Boelaert M
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):838-41. PubMed ID: 16406035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
    Meheus F; Abuzaid AA; Baltussen R; Younis BM; Balasegaram M; Khalil EAG; Boelaert M; Musa AM
    Am J Trop Med Hyg; 2013 Dec; 89(6):1146-1153. PubMed ID: 24189368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil.
    de Carvalho IPSF; Peixoto HM; Romero GAS; de Oliveira MRF
    Trop Med Int Health; 2019 Sep; 24(9):1064-1077. PubMed ID: 31278808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological patterns of mortality due to visceral leishmaniasis and HIV/AIDS co-infection in Brazil, 2000-2011.
    Martins-Melo FR; Lima Mda S; Alencar CH; Ramos AN; Heukelbach J
    Trans R Soc Trop Med Hyg; 2014 Jun; 108(6):338-47. PubMed ID: 24706340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The household costs of visceral leishmaniasis care in south-eastern Nepal.
    Uranw S; Meheus F; Baltussen R; Rijal S; Boelaert M
    PLoS Negl Trop Dis; 2013; 7(2):e2062. PubMed ID: 23469298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snakebite envenomation in the Brazilian Amazon: a cost-of-illness study.
    Magalhães SFV; Peixoto HM; de Almeida Gonçalves Sachett J; Oliveira SS; Alves EC; Dos Santos Ibiapina HN; Monteiro WM; de Oliveira MRF
    Trans R Soc Trop Med Hyg; 2020 Sep; 114(9):635-642. PubMed ID: 32239168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis.
    Silva Ferreira de Carvalho IP; Peixoto HM; Sierra Romero GA; Fernandes de Oliveira MR
    Value Health Reg Issues; 2020 Dec; 23():77-84. PubMed ID: 32961526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource utilization and cost of rheumatic fever.
    Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
    J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
    Thornton SJ; Wasan KM; Piecuch A; Lynd LL; Wasan EK
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1312-9. PubMed ID: 20545513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of implementation and direct cost estimates for diagnostic tests for human visceral leishmaniasis in an urban area in Brazil.
    Assis TS; Guimarães PN; Oliveira E; Peruhype-Magalhães V; Gomes LI; Rabello A
    Cad Saude Publica; 2015 Oct; 31(10):2127-36. PubMed ID: 26735380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome associated with Zika virus infection in Brazil: a cost-of-illness study.
    Peixoto HM; Romero GAS; de Araújo WN; de Oliveira MRF
    Trans R Soc Trop Med Hyg; 2019 May; 113(5):252-258. PubMed ID: 30892628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic impact of visceral leishmaniasis on households in Bangladesh.
    Anoopa Sharma D; Bern C; Varghese B; Chowdhury R; Haque R; Ali M; Amann J; Ahluwalia IB; Wagatsuma Y; Breiman RF; Maguire JH; McFarland DA
    Trop Med Int Health; 2006 May; 11(5):757-64. PubMed ID: 16640630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.
    Olliaro P; Darley S; Laxminarayan R; Sundar S
    Trop Med Int Health; 2009 Aug; 14(8):918-25. PubMed ID: 19563434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent class analysis of diagnostic tests for visceral leishmaniasis in Brazil.
    Machado de Assis TS; Rabello A; Werneck GL
    Trop Med Int Health; 2012 Oct; 17(10):1202-7. PubMed ID: 22897740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.